| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 03/13/2008 | WO2008013664A3 Methods of producing pancreatic hormones |
| 03/13/2008 | WO2007148098A3 Methods of producing and propagating neural precursor cells |
| 03/13/2008 | WO2007146334A9 Co-culture lymphoid tissue equivalent (lte) for an artificial immune system (ais) |
| 03/13/2008 | WO2007137769A3 Method for the in vitro preparation of living cells and/or cell accumulations from tissue |
| 03/13/2008 | WO2007133352A3 Macrocyclic kinase inhibitors |
| 03/13/2008 | WO2007130697A3 Anti-ephb4 antibodies and methods using same |
| 03/13/2008 | WO2007127809A3 P8 modulation to control hypertension |
| 03/13/2008 | WO2007109441A3 Polypeptides having endoglucanase activity and polynucleotides encoding same |
| 03/13/2008 | WO2007090102A3 Biomimetic scaffolds |
| 03/13/2008 | WO2007057693A3 Biocompatible substrate and method for manufacture and use thereof |
| 03/13/2008 | WO2006117671A8 Method for carrying a serum- and protein-free cultivation of stem and progenitor cells |
| 03/13/2008 | US20080066206 Expression vector comprising nucleotide sequences which express cleavable short interfering nucleic acid for use as tool in controlling gene expression in plants |
| 03/13/2008 | US20080066204 Nucleotide sequences coding isomerase for use as tool in enhancing starch biosynthesis in plants |
| 03/13/2008 | US20080066201 Nucleic acid molecules and other molecules associated with plants |
| 03/13/2008 | US20080066200 Transgenic plant which serves as bioreactor for expression of humanized glycoproteins with reduced fucose and xylose residues |
| 03/13/2008 | US20080066198 Modulation of Flowering Time and Growth Cessation in Perennial Plants |
| 03/13/2008 | US20080066197 Pluripotent cells from rat and other species |
| 03/13/2008 | US20080066195 Taste Receptors of the T1r Family Form Domestic Cat |
| 03/13/2008 | US20080064859 Recombinant MHC molecules useful for manipulation of antigen-specific T-cells |
| 03/13/2008 | US20080064857 Immunoglobulin for use in diagnosis, prevention and treatment of metabolic disorders of pancreas |
| 03/13/2008 | US20080064764 Isolated nucleic acids; antibody for selective binding; biodrug treating osteoporosis, osteoblast, bone disorders, osteocalcin mediated disorder |
| 03/13/2008 | US20080064741 Bioavailable diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complex |
| 03/13/2008 | US20080064700 Aryl triazines as LPAAT-beta inhibitors and uses thereof |
| 03/13/2008 | US20080064690 Neuropathic or inflammatory pain relief; inhibiting ion flux through channel including PN3 subunit; potency |
| 03/13/2008 | US20080064671 Combinations containing a 4-acylaminopyridine derivative |
| 03/13/2008 | US20080064666 Cystic fibrosis transmembrane conductance regulator protein inhibitors and uses thereof |
| 03/13/2008 | US20080064649 Anticarcinogenic and antiproliferative agents in combination with radiation therapy, chemotherapy, ablative surgery, or partially ablative surgery for bone and breast cancer treatments |
| 03/13/2008 | US20080064647 A polyvalent multimeric complex formed from a plurality of circularly permuted chimeric pRNA molecules, each carrying a stabilized biologically active moiety; degradation resistant stabilized ribozyme is correctly folded such that it remains intracellularly active |
| 03/13/2008 | US20080064646 Lactobacillus Fermentum N-Desoxyribosyl Transferases and the Use Thereof for Enzymatic Synthesis of 2', 3' - Didesoxynucleosides and 2',3'- Didehydro-2',3'- Didesoxynucleosides |
| 03/13/2008 | US20080064645 A carbohydrate linked to a fluorophore through a 2-amido-2-(1-hydroxyalkyl)ethoxy linkage; inhibition of caveolar endocytosis, plasma membrane microdomain formation, virus binding and infection, transmembrane signaling, and integrin function in cells; anticarcinogenic and antiinflammatory agents |
| 03/13/2008 | US20080064630 Prolonged circulation time; combined with such as human growth hormone or fragments; nucleic acid constructs, vectors, host cells; culturing and harvesting |
| 03/13/2008 | US20080064107 Use of multiple transformation enhancer sequences to improve plant transformation efficiency |
| 03/13/2008 | US20080064106 Lentiviral LTR-deleted vector |
| 03/13/2008 | US20080064105 Animal protein-free media for cultivation of cells |
| 03/13/2008 | US20080064104 Antagonists and agonists of ldcam and methods of use |
| 03/13/2008 | US20080064103 Identifying regulatory compounds which dissociate/destsbilize receptor/ligand binding activity; for use in controlled immune suppression |
| 03/13/2008 | US20080064102 Transiently immortalized cells for use in gene therapy |
| 03/13/2008 | US20080064101 Lymphoid tissue-specific cell production from hematopoietic progenitor cells in three-dimensional devices |
| 03/13/2008 | US20080064100 Culturing urogenital tissue for use in In vitro fertilization |
| 03/13/2008 | US20080064099 Propagating progenitor cell line from cell isolated from inner cell mass tissues; in vitro fertilization |
| 03/13/2008 | US20080064098 Procurement, isolation and cryopreservation of maternal placental cells |
| 03/13/2008 | US20080064097 Leafhopper ecdysone receptor nucleic acids, polypeptides, and uses thereof |
| 03/13/2008 | US20080064096 Isolated nucleic acid molecules which encode a soluble IL-TIF receptor or binding protein which binds to IL-TIF/IL-22, and uses thereof |
| 03/13/2008 | US20080064095 Method for obtaining mastocyte lines from pig tissues and for producing heparin-type modules |
| 03/13/2008 | US20080064094 Polynucleotides encoding two novel human G-protein coupled receptors, HGPRBMY28 and HGPRBMY29, and splice variants thereof |
| 03/13/2008 | US20080064093 Compositions and methods employing zwitterionic detergent combinations |
| 03/13/2008 | US20080064084 Method For Producing Recombinant Trypsin |
| 03/13/2008 | US20080064081 Reducing antigenicity of viral protein via amino acid sequence variation; enhancing vector transferability during gene therapy |
| 03/13/2008 | US20080064069 Protein comprising uridine diphosphate-glucose 4,6-dehydratase, uridine diphosphate-4-keto-6-deoxyglucose 3,5-epimerase and uridine diphosphate-4-keto-rhamnose 4-keto-reductase for use in glycoengineering of polypeptides |
| 03/13/2008 | US20080064064 Mannanases |
| 03/13/2008 | US20080064063 Compositions and methods for producing steviol and steviol glycosides |
| 03/13/2008 | US20080064054 Substrate for accurate monitoring/determining presence or absence of clostridial toxin |
| 03/13/2008 | US20080064049 Compositions and methods for treating and diagnosing cancer |
| 03/13/2008 | US20080064048 Using ubiquitin specific immunoglobulins to identify and harvest nervous system tissues; tissue targeted therapy; antitumor agents |
| 03/13/2008 | US20080064034 Multi-Cellular Test Systems |
| 03/13/2008 | US20080063701 Lipids of a liposome comprising cationic N1-cholesteryloxycarbonyl-3,7-diazanononane-1,9-diamine and/or noncationic dioleoyl phosphatidylethanolamine and short interference RNA (siRNA) are coupled, reversibly or irreversibly, to one or more polymers; drug delivery; freeze drying |
| 03/13/2008 | US20080063691 Fatty Acid Desaturases From Primula |
| 03/13/2008 | US20080063655 nucleic acid sequences encoding a 30 kD Brachyspira hyodysenteriae lipoprotein; host cell; new locus comprising four genes has now surprisingly been found; swine dysentery |
| 03/13/2008 | US20080063652 co-culture of hematopoietic progenitor cells and lymphoreticular stromal cells in a porous solid scaffold, resulting in unexpectedly high numbers of regulatory T cells |
| 03/13/2008 | US20080063643 HLA-binding motif in its sequence; recognized by an HLA-A2- or HLA-A24-restricted cytotoxic T cell; nucleotide; antibody; vector; diagnosid and prognosis of hepatitis C virus infection |
| 03/13/2008 | US20080063641 Comprise a single antigen binding arm and an Fc region; exhibits enhanced stability in vivo compared to a Fab antibody fragment |
| 03/13/2008 | US20080063636 polypeptides having deletions in the amino acid sequence, useful as antigens for improving vaccine therapy; treatment of Alzheimer's disease |
| 03/13/2008 | US20080063630 polynucleotides that code for polypeptides having activity for targeting heterogeneous polypeptides to the surfaces of cytoplasmic membranes, useful for analysis of proteind, delivery of cells expressing the polypeptide to a target site in vivo, preparation of an antibodies and vaccines, and gene therapy |
| 03/13/2008 | US20080063629 culturing progenitor or stem cells with stromal cells in cytokines; genetic engineering |
| 03/13/2008 | US20080063628 increasing gene expression of genetic transcriptional regulators, using chromatin-remodeling agent comprising histone deacetylase inhibitors; cells used in the therapeutic treatment of diabetes |
| 03/13/2008 | US20080063627 collagenous tissue scaffolds bonded to biocompatibilzers via activated photoreactive groups; tissue engineering; reducing transplant rejection |
| 03/13/2008 | US20080063600 use of deactivated lymphocytes, antibodies, drug mixtures and adjuvants, for the treatment or prevention of Cruetzfield-Jacobs disease in humans or animals; immunology; bioassays |
| 03/13/2008 | US20080063598 chimeric antibodies, fragments, polypeptides and derivatives that preferentially bind tumor associated antigens (AF-20), useful in the treatment and diagnosis of cancers |
| 03/13/2008 | DE102005050723B4 Verfahren zur Aufbereitung der unbefruchteten Eier von Wassertieren zu Delikatess-Nahrungsmitteln und mit dem Verfahren aufbereitete Eier Process for the preparation of the unfertilized eggs of aquatic animals delicatessen food and prepared by the method of eggs |
| 03/13/2008 | CA2663388A1 Human binding molecules capable of neutralizing influenza virus h5n1 and uses thereof |
| 03/13/2008 | CA2662755A1 Suppressor trna transcription in vertebrate cells |
| 03/13/2008 | CA2662753A1 Hybrid suppressor trna for vertebrate cells |
| 03/13/2008 | CA2662752A1 Site specific incorporation of non-natural amino acids by vertebrate cells |
| 03/13/2008 | CA2662624A1 Fluorescent cell markers |
| 03/13/2008 | CA2662350A1 Antibodies to bone morphogenic proteins and receptors therefor and methods for their use |
| 03/13/2008 | CA2662340A1 Humanized anti-cd19 antibodies and their use in treatment of oncology, transplantation and autoimmune disease |
| 03/13/2008 | CA2662231A1 A method for producing langerhans cells and/or dermal/interstitial dendritic cells from cd14+ monocytes |
| 03/13/2008 | CA2662226A1 Fully human high yield production system for improved antibodies and proteins |
| 03/13/2008 | CA2661308A1 Neukinase, a downstream protein of neuregulin |
| 03/12/2008 | EP1897952A2 Methyltransferasegenes and uses thereof |
| 03/12/2008 | EP1897950A2 Human GIL-19/AE289 proteins and polynucleotides encoding same |
| 03/12/2008 | EP1897949A2 Human interleukin-B50. Therapeutic uses |
| 03/12/2008 | EP1897942A1 Antisense oligonucleotides which combat aberrant splicing and methods of using the same |
| 03/12/2008 | EP1897937A1 Method of culturing NPCs |
| 03/12/2008 | EP1897936A1 Culture substrate with an oxidized silicon surface |
| 03/12/2008 | EP1897889A2 Method of modulating the profileration of medullary thyroid carcinoma cells |
| 03/12/2008 | EP1897553A1 Inhibitor of stem cell proliferation and uses thereof |
| 03/12/2008 | EP1897548A1 T cell regulation |
| 03/12/2008 | EP1897540A2 Inhibition of STAT3 signal transduction for human cancer therapy |
| 03/12/2008 | EP1896596A2 Methods for altering the reactivity of plant cell walls |
| 03/12/2008 | EP1896590A2 Serum-free stable transfection and production of recombinant human proteins in human cell lines |
| 03/12/2008 | EP1896587A2 METHODS FOR PRODUCING MICRORNAs |
| 03/12/2008 | EP1896582A1 Human monoclonal antibodies to programmed death 1(pd-1) and methods for treating cancer using anti-pd-1 antibodies alone or in combination with other immunotherapeutics |
| 03/12/2008 | EP1896578A1 Piggybac as a tool for genetic manipulation and analysis in vertebrates |
| 03/12/2008 | EP1896573A1 Mutant cells suitable for recombinant polypeptide production |
| 03/12/2008 | EP1896572A2 Method of producing organotypic cell cultures |
| 03/12/2008 | EP1896571A1 Materials and methods relating to cell based therapies |
| 03/12/2008 | EP1896570A2 Cellular vaccine and use thereof |
| 03/12/2008 | EP1896569A1 Method for differentiation of stem cells |
| 03/12/2008 | EP1896568A2 Components of cell culture media produced from plant cells |